Characteristic of the complete chloroplast genome of Symphoricarpos sinensis, an important ornamental plant endemic to China

od Zhang, Yi, Zhang, Qing Yuan, Ran, Hang, Cao, Yanan
izdano v Mitochondrial DNA B Resour (2020)

Neoadjuvant Chemoradiotherapy vesus Chemotherapy alone Followed by Surgery for Resectable Stage III Non-Small-Cell Lung Cancer: a Meta-Analysis

od Guo, Shan xian, Jian, Yan, Chen, Ying lan, Cai, Yun, Zhang, Qing yuan, Tou, Fang fang
izdano v Sci Rep (2016)

Estrogen receptor α mediates the effects of notoginsenoside R1 on endotoxin-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes

od ZHONG, LEI, ZHOU, XING-LU, LIU, YAN-SONG, WANG, YI-MIN, MA, FEI, GUO, BAO-LIANG, YAN, ZHAO-QI, ZHANG, QING-YUAN
izdano v Mol Med Rep (2015)

Managing Pain in Patients With Cancer: The Chinese Good Pain Management Experience

od Yu, Shi-Ying, Wang, Jie-Jun, Huang, Yu-guang, Hu, Bing, Wang, Kun, Li, Ping Ping, Wu, Yi-Long, Zhang, He-Long, Zhang, Li, Zhang, Qing-Yuan, Qin, Shu-Kui
izdano v J Glob Oncol (2016)

Molecular Subtyping of Triple‐Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance

od Zhao, Shen, Ma, Ding, Xiao, Yi, Li, Xiao‐Mei, Ma, Jian‐Li, Zhang, Han, Xu, Xiao‐Li, Lv, Hong, Jiang, Wen‐Hua, Yang, Wen‐Tao, Jiang, Yi‐Zhou, Zhang, Qing‐Yuan, Shao, Zhi‐Ming
izdano v Oncologist (2020)

A Polymorphism at the 3′-UTR Region of the Aromatase Gene Is Associated with the Efficacy of the Aromatase Inhibitor, Anastrozole, in Metastatic Breast Carcinoma

od Liu, Lei, Bai, Yu-Xian, Zhou, Jian-Hua, Sun, Xiu-Wei, Sui, Hong, Zhang, Wen-Jie, Yuan, Heng-Heng, Xie, Rui, Wei, Xiao-Li, Zhang, Ting-Ting, Huang, Peng, Li, Yan-Jing, Wang, Jing-Xuan, Zhao, Shu, Zhang, Qing-Yuan
Izdano 2013

Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)

od Wang, Feng-Hua, Wei, Xiao-Li, Feng, Jifeng, Li, Qi, Xu, Nong, Hu, Xi-Chun, Liao, Wangjun, Jiang, Yi, Lin, Xiao-Yan, Zhang, Qing-yuan, Yuan, Xiang-Lin, Huang, Hai-Xin, Chen, Ye, Dai, Guang-Hai, Shi, Jian-Hua, Shen, Lin, Yang, Shu-Jun, Shu, Yong-Qian, Liu, Yun-Peng, Wang, Weifeng, Wu, Hai, Feng, Hui, Yao, Sheng, Xu, Rui-Hua
izdano v J Clin Oncol (2021)

MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study

od Zhang, Qing Yuan, Sun, Tao, Yin, Yong Mei, Li, Hui Ping, Yan, Min, Tong, Zhong Sheng, Oppermann, Christina P., Liu, Yun Peng, Costa, Romulo, Li, Man, Cheng, Ying, Ouyang, Qu Chang, Chen, Xi, Liao, Ning, Wu, Xin Hong, Wang, Xiao Jia, Feng, Ji Feng, Hegg, Roberto, Kanakasetty, G.B., Coccia-Portugal, Maria A., Han, Ru Bing, Lu, Yi, Chi, Hai Dong, Jiang, Ze Fei, Hu, Xi Chun
izdano v Ther Adv Med Oncol (2020)

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2−, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

od Johnston, Stephen R. D., Harbeck, Nadia, Hegg, Roberto, Toi, Masakazu, Martin, Miguel, Shao, Zhi Min, Zhang, Qing Yuan, Martinez Rodriguez, Jorge Luis, Campone, Mario, Hamilton, Erika, Sohn, Joohyuk, Guarneri, Valentina, Okada, Morihito, Boyle, Frances, Neven, Patrick, Cortés, Javier, Huober, Jens, Wardley, Andrew, Tolaney, Sara M., Cicin, Irfan, Smith, Ian C., Frenzel, Martin, Headley, Desirée, Wei, Ran, San Antonio, Belen, Hulstijn, Maarten, Cox, Joanne, O’Shaughnessy, Joyce, Rastogi, Priya
izdano v J Clin Oncol (2020)